NO20084524L - Farmasoytisk sammensetning inneholdende NMB0938-protein - Google Patents

Farmasoytisk sammensetning inneholdende NMB0938-protein

Info

Publication number
NO20084524L
NO20084524L NO20084524A NO20084524A NO20084524L NO 20084524 L NO20084524 L NO 20084524L NO 20084524 A NO20084524 A NO 20084524A NO 20084524 A NO20084524 A NO 20084524A NO 20084524 L NO20084524 L NO 20084524L
Authority
NO
Norway
Prior art keywords
nmb0938
protein
present
field
pharmaceutical composition
Prior art date
Application number
NO20084524A
Other languages
English (en)
Inventor
Sonia Gonzalez Blanco
Rolando Pajon Feyt
Gretel Sardinas Garcia
Darien Garcia Diaz
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of NO20084524L publication Critical patent/NO20084524L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

S a m m e n d r a g Foreliggende oppfinnelse angår området medisin og spesielt utviklingen av en farmasøytisk formulering inneholdende NMB0938-protein. Formuleringen som er beskrevet i foreliggende oppfinnelse, er i stand til å gi beskyttelse mot forskjellige sykdommer forårsaket av patogene materialer. NMB0938-protein ble identifisert som en Neisseria meningitidis yttermenbranvesikkel (OMV) -komponent og den ble oppnådd via rekombinant DNA-teknologi idet dens immunogenisitets- og beskyttende aktivitet ble evaluert i dyremodeller. Grunnet det høye konserveringsnivå har det NMB0938-kodende gen vist at farmasøytiske sammensetninger inneholdende dette protein har en høy verdi som induserer for en kryssreaktiv immunrespons. Formuleringer presentert i foreliggende oppfinnelse kan anvendes innen området humanmedisin.
NO20084524A 2006-03-31 2008-10-28 Farmasoytisk sammensetning inneholdende NMB0938-protein NO20084524L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20060074A CU23572A1 (es) 2006-03-31 2006-03-31 Composición farmacéutica que comprende la proteína nmb0938
PCT/CU2007/000011 WO2007112702A2 (es) 2006-03-31 2007-03-29 Composición farmacéutica que comprende la proteína nmb0938

Publications (1)

Publication Number Publication Date
NO20084524L true NO20084524L (no) 2008-12-03

Family

ID=38461832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084524A NO20084524L (no) 2006-03-31 2008-10-28 Farmasoytisk sammensetning inneholdende NMB0938-protein

Country Status (13)

Country Link
US (1) US20090297547A1 (no)
EP (1) EP2011511A2 (no)
KR (1) KR20080106985A (no)
CN (1) CN101448522A (no)
AR (1) AR060796A1 (no)
AU (1) AU2007234213A1 (no)
BR (1) BRPI0710064A2 (no)
CA (1) CA2649321A1 (no)
CU (1) CU23572A1 (no)
MX (1) MX2008012664A (no)
NO (1) NO20084524L (no)
WO (1) WO2007112702A2 (no)
ZA (1) ZA200808769B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104079247B (zh) 2013-03-26 2018-02-09 杜比实验室特许公司 均衡器控制器和控制方法以及音频再现设备
CN107093991B (zh) 2013-03-26 2020-10-09 杜比实验室特许公司 基于目标响度的响度归一化方法和设备
DK3506935T3 (en) 2016-09-02 2024-04-02 Sanofi Pasteur Inc Neisseria meningitidis-vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ541361A (en) * 1998-05-01 2008-04-30 Inst Genomic Research Neisseria meningitidis antigens and compositions relating to SEQ ID Nos:2916, 2918 and 2920
NZ545647A (en) * 1999-05-19 2008-02-29 Chiron Srl Combination neisserial compositions
CU23236A1 (es) * 2003-12-03 2007-09-26 Ct Ingenieria Genetica Biotech PROTEINA NMB0928 Y SU USO EN FORMULACIONES FARMACéUTICAS P

Also Published As

Publication number Publication date
CU23572A1 (es) 2010-09-30
AR060796A1 (es) 2008-07-16
WO2007112702A2 (es) 2007-10-11
CN101448522A (zh) 2009-06-03
ZA200808769B (en) 2009-09-11
US20090297547A1 (en) 2009-12-03
KR20080106985A (ko) 2008-12-09
EP2011511A2 (en) 2009-01-07
BRPI0710064A2 (pt) 2011-08-02
AU2007234213A1 (en) 2007-10-11
WO2007112702A3 (es) 2007-11-22
MX2008012664A (es) 2008-10-13
CA2649321A1 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
Cheng et al. Developing a new generation of antimicrobial and bioactive dental resins
UA99659C2 (uk) Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
NZ601538A (en) Vaccine compositions comprising a mutated factor h binding protein
MX2009006760A (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedades meningococicas.
BR112012022676A2 (pt) composição imunogênica, métodos para tratamento ou prevenção de infecção ou doença, para fabricar uma composição imunogênica e para melhorar uma vacina, e, kit
MA34030B1 (fr) Formulations pharmaceutiques solides comprenant du bibw 2992
WO2011110655A3 (en) Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease
NO20064584L (no) Tetrahydropyridoindolderivater
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
CU23932B1 (es) Sales farmacéuticamente aceptables de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo y sus usos en terapia
BRPI0515209A (pt) compostos, composição cosmética, usos de uma composição e composição farmacêutica
Cho et al. In vivo inhibition of Porphyromonas gingivalis growth and prevention of periodontitis with quorum‐sensing inhibitors
WO2007118963A3 (fr) Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
NO20070665L (no) Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer
NO20084524L (no) Farmasoytisk sammensetning inneholdende NMB0938-protein
MX2009012713A (es) Nuevos derivados de acido 3-fenil acrilico de receptores de tipo ppar, su metodo de preparacion y su uso en composiciones cosmeticas o farmaceuticas.
NO20090067L (no) Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer
NO20063017L (no) Protein NMB0928 og anvendelse derav i farmasoytiske formuleringer
NO20073046L (no) Utvalgte benzofuranderivater
BR112014007491A2 (pt) sequências de aminoácidos para o controle de patógenos
NO20084525L (no) Farmasoytiske sammensetninger inneholdende NMB0606-protein
NO20083318L (no) Farmasoytiske sammensetninger inneholdende protein NMA0939

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application